z-logo
open-access-imgOpen Access
Identification and Assessment of Anderson-Fabry Disease by Cardiovascular Magnetic Resonance Noncontrast Myocardial T1 Mapping
Author(s) -
Daniel Sado,
Steven K White,
Stefan K. Piechnik,
Sanjay M Banypersad,
Thomas A. Treibel,
Gabriella Captur,
Marianna Fontana,
Viviana Maestrini,
Andrew Flett,
Matthew D. Robson,
Robin Lachmann,
Elaine Murphy,
Atul Mehta,
Derralynn Hughes,
Stefan Neubauer,
Perry Elliott,
James Moon
Publication year - 2013
Publication title -
circulation cardiovascular imaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.584
H-Index - 99
eISSN - 1942-0080
pISSN - 1941-9651
DOI - 10.1161/circimaging.112.000070
Subject(s) - medicine , left ventricular hypertrophy , cardiology , magnetic resonance imaging , cardiac amyloidosis , cardiomyopathy , hypertensive heart disease , hypertrophic cardiomyopathy , stenosis , amyloidosis , radiology , heart failure , blood pressure
Anderson-Fabry disease (AFD) is a rare but underdiagnosed intracellular lipid disorder that can cause left ventricular hypertrophy (LVH). Lipid is known to shorten the magnetic resonance imaging parameter T1. We hypothesized that noncontrast T1 mapping by cardiovascular magnetic resonance would provide a novel and useful measure in this disease with potential to detect early cardiac involvement and distinguish AFD LVH from other causes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom